EGR3 activates related inflammatory signaling pathways (such as the NF-kb pathway) by activating the expression of IL-6 and IL-8, which are closely related to the occurrence and development of cancer (Baron et al., 2014). This evidence concerns the gene CXCL8 and cancer.